STRs in panel
Prev Next
Regions in panel
Prev Next

Hyperparathyroidism

Gene: RET

Green List (high evidence)

RET (ret proto-oncogene)
EnsemblGeneIds (GRCh38): ENSG00000165731
EnsemblGeneIds (GRCh37): ENSG00000165731
OMIM: 164761, ClinGen, DECIPHER
RET is in 24 panels

2 reviews

Chirag Patel (Genetic Health Queensland)

Green List (high evidence)

Well established gene-disease association, hyperparathyroidism is a feature.
Sources: Expert list
Created: 28 Nov 2022, 5:04 p.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Multiple endocrine neoplasia IIA, MIM# 171400; Multiple endocrine neoplasia IIB, MIM# 162300

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

Well established gene-disease association, hyperparathyroidism is a feature.
Sources: Expert Review
Created: 31 Mar 2021, 2:31 p.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Multiple endocrine neoplasia IIA, MIM# 171400; Multiple endocrine neoplasia IIB, MIM# 162300

History Filter Activity

29 Jan 2026, Gel status: 3

Entity classified by Genomics England curator

Chirag Patel (Genetic Health Queensland)

Gene: ret has been classified as Green List (High Evidence).

29 Jan 2026, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Chirag Patel (Genetic Health Queensland)

gene: RET was added gene: RET was added to Hyperparathyroidism. Sources: Expert Review Green,Expert list,Expert Review Green,Expert Review Mode of inheritance for gene: RET was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Phenotypes for gene: RET were set to Multiple endocrine neoplasia IIA, MIM# 171400; Multiple endocrine neoplasia IIB, MIM# 162300